Advanced Therapeutics

Papers
(The H4-Index of Advanced Therapeutics is 21. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Polymeric Nanoparticles for Nasal Drug Delivery to the Brain: Relevance to Alzheimer's Disease73
Engineering Strategies for Immunomodulatory Cytokine Therapies: Challenges and Clinical Progress47
Alkaline Phosphatase: A Reliable Endogenous Partner for Drug Delivery and Diagnostics43
SQ3370 Activates Cytotoxic Drug via Click Chemistry at Tumor and Elicits Sustained Responses in Injected and Non‐Injected Lesions40
A Manganese Phosphate Nanocluster Activates the cGAS‐STING Pathway for Enhanced Cancer Immunotherapy35
Engineering Gene Therapy: Advances and Barriers34
Mn3O4 Nanozyme for Inflammatory Bowel Disease Therapy34
The Effects of Localized Heat on the Hallmarks of Cancer31
Establishments and Evaluations of Post‐Operative Adhesion Animal Models31
Local Depletion of Immune Checkpoint Ligand CTLA4 Expressing Cells in Tumor Beds Enhances Antitumor Host Immunity29
Engineered Multivalent Nanobodies Potently and Broadly Neutralize SARS‐CoV‐2 Variants28
A 3D‐Bioprinted Vascularized Glioblastoma‐on‐a‐Chip for Studying the Impact of Simulated Microgravity as a Novel Pre‐Clinical Approach in Brain Tumor Therapy27
Toward Hijacking Bioelectricity in Cancer to Develop New Bioelectronic Medicine26
Preventive Efficacy of a Tenofovir Alafenamide Fumarate Nanofluidic Implant in SHIV‐Challenged Nonhuman Primates26
A Single‐Dose, Implant‐Based, Trivalent Virus‐like Particle Vaccine against “Cholesterol Checkpoint” Proteins24
Photothermal Therapy Combined with Neoantigen Cancer Vaccination for Effective Immunotherapy against Large Established Tumors and Distant Metastasis24
Drug Repurposing of Itraconazole and Estradiol Benzoate against COVID‐19 by Blocking SARS‐CoV‐2 Spike Protein‐Mediated Membrane Fusion23
Ultrasound‐Responsive Microfluidic Microbubbles for Combination Tumor Treatment23
Delivery of Nanoconstructs in Cancer Therapy: Challenges and Therapeutic Opportunities22
Materials and Cytokines in the Healing of Diabetic Foot Ulcers22
Classical Complement Pathway Inhibition in a “Human‐On‐A‐Chip” Model of Autoimmune Demyelinating Neuropathies22
Dynamic Hydrogels for Prevention of Post‐Operative Peritoneal Adhesions21
The Combination of Morphology and Surface Chemistry Defines the Immunological Identity of Nanocarriers in Human Blood21
0.052384853363037